{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T19:14:56Z","timestamp":1781118896943,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AR007534"],"award-info":[{"award-number":["T32 AR007534"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Linda Crnic Institute for Down Syndrome","award":["Linda Crnic Institute for Down Syndrome"],"award-info":[{"award-number":["Linda Crnic Institute for Down Syndrome"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Respiratory conditions are the leading cause of hospitalization and death in children with Trisomy 21 (T21). Diffuse alveolar hemorrhage (DAH) occurs at higher frequency in children with T21; yet, it is not widely studied nor is there a standardized approach to diagnosis or management. The objective of this study was to identify children with T21 and DAH in order to understand contributing factors and identify opportunities to improve outcomes. We identified 5 children with T21 at a single institution with histology-proven DAH over 10\u2009years and discuss their presentation, evaluation, management, and outcomes. We also reviewed the cases in the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>Patient 1 died at age seven due to secondary hemophagocytic lymphohistiocytosis. DAH was seen on autopsy. Patient 2 was a three-year-old with systemic-onset juvenile idiopathic arthritis diagnosed with DAH after presenting for hypoxia. Patient 3 was diagnosed with DAH at age nine after presenting with recurrent suspected pneumonia and aspiration. Patient 4 was diagnosed with DAH at age eight after presenting with pallor and fatigue. She had additional ICU admissions for DAH with infections. Patient 5 developed hemoptysis at age three and had recurrent DAH for 10 years. Four patients responded positively to immune-modulation such as intravenous immunoglobulin, glucocorticoids, and rituximab. Of the 19 patients identified in the literature, only one was from the United States. The majority had anemia, respiratory distress, autoantibodies, and recurrences. Very few patients had hemoptysis. Idiopathic pulmonary hemosiderosis was the most common diagnosis. Almost all received glucocorticoids with or without additional immunosuppression. The majority of our patients and those in the literature had positive auto-antibodies such as anti-neutrophil cytoplasmic antibodies and anti-nuclear antigen antibodies. Diagnostic clues included respiratory distress, hypoxia, anemia, recurrent pneumonia, and\/or ground glass opacities on imaging. We identified four contributors to DAH: structural lung abnormalities, pulmonary arterial hypertension, infection\/aspiration, and autoimmune disease\/immune dysregulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These cases demonstrate the need for an increased index of suspicion for DAH in children with T21, particularly given the low frequency of hemoptysis at presentation, enrich the understanding of risk factors, and highlight the favorable response to immunosuppressive therapies in this vulnerable population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-021-00592-4","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T03:03:06Z","timestamp":1626490986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Diffuse alveolar hemorrhage in children with trisomy 21"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7645-2084","authenticated-orcid":false,"given":"Jessica L.","family":"Bloom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Weinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Galambos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean T.","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah R.","family":"Liptzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Fuhlbrigge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,17]]},"reference":[{"issue":"3","key":"592_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/ped.12349","volume":"56","author":"T Saji","year":"2014","unstructured":"Saji T. Clinical characteristics of pulmonary arterial hypertension associated with Down syndrome. Pediatr Int. 2014;56(3):297\u2013303.","journal-title":"Pediatr Int"},{"issue":"8","key":"592_CR2","doi-asserted-by":"publisher","first-page":"e70401","DOI":"10.1371\/journal.pone.0070401","volume":"8","author":"P Fitzgerald","year":"2013","unstructured":"Fitzgerald P, Leonard H, Pikora T, Bourke J, Hammond G. Hospital admissions in children with Down syndrome: experience of a population-based cohort followed from birth. PLoS One. 2013;8(8):e70401.","journal-title":"PLoS One"},{"issue":"6","key":"592_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/jpc.13214","volume":"52","author":"C Joffre","year":"2016","unstructured":"Joffre C, Lesage F, Bustarret O, Hubert P, Oualha M. Children with Down syndrome: clinical course and mortality-associated factors in a French medical paediatric intensive care unit. J Paediatr Child Health. 2016;52(6):595\u20139.","journal-title":"J Paediatr Child Health"},{"key":"592_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1440-1754.1999.00386.x","volume":"35","author":"J Hilton","year":"1999","unstructured":"Hilton J, Fitzgerald D, Cooper D. Respiratory morbidity of hospitalized children with trisomy 21. J Paediatr Child Health. 1999;35:383\u20136.","journal-title":"J Paediatr Child Health"},{"issue":"12","key":"592_CR5","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00134-007-0803-z","volume":"33","author":"M Bruijn","year":"2007","unstructured":"Bruijn M, van der Aa LB, van Rijn RR, Bos AP, van Woensel JB. High incidence of acute lung injury in children with Down syndrome. Intensive Care Med. 2007;33(12):2179\u201382.","journal-title":"Intensive Care Med"},{"issue":"3","key":"592_CR6","first-page":"63","volume":"23","author":"D Parris","year":"2017","unstructured":"Parris D, Van Niekerk A, Jeevarathnum A, Green R. An approach to pulmonary haemorrhage in children. S Afr Respir J. 2017;23(3):63\u201370.","journal-title":"S Afr Respir J"},{"issue":"1","key":"592_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13023-018-0806-6","volume":"13","author":"A Alimi","year":"2018","unstructured":"Alimi A, Taytard J, Abou Taam R, et al. Pulmonary hemosiderosis in children with Down syndrome: a national experience. Orphanet J Rare Dis. 2018;13(1):60.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"592_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/0300060518800652","volume":"47","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Luo F, Wang N, Song Y, Tao Y. Clinical characteristics and prognosis of idiopathic pulmonary hemosiderosis in pediatric patients. J Int Med Res. 2019;47(1):293\u2013302.","journal-title":"J Int Med Res"},{"issue":"4","key":"592_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4046\/trd.2013.74.4.151","volume":"74","author":"MS Park","year":"2013","unstructured":"Park MS. Diffuse alveolar hemorrhage. Tuberc Respir Dis (Seoul). 2013;74(4):151\u201362.","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"3","key":"592_CR10","first-page":"470","volume":"14","author":"J Rayment","year":"2017","unstructured":"Rayment J, Cutz E, Levy D, Dell S. Concomitant diffuse alveolar hemorrhage and pulmonary embolism in a child with isolated pulmonary Capillaritis. AnnalsATS. 2017;14(3):470\u20132.","journal-title":"AnnalsATS."},{"issue":"5","key":"592_CR11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/ped.12690","volume":"57","author":"H Watanabe","year":"2015","unstructured":"Watanabe H, Ayusawa M, Kato M, et al. Idiopathic pulmonary hemosiderosis complicated by Down syndrome. Pediatr Int. 2015;57(5):1009\u201312.","journal-title":"Pediatr Int"},{"key":"592_CR12","first-page":"58","volume":"28","author":"A Aceti","year":"2011","unstructured":"Aceti A, Sciutti R, Bracci P, Bertelli L, Melchionda F, Cazzato S. Idiopathic pulmonary haemosiderosis in a child with Down\u2019s syndrome: case report and review of the literature. Sarcoidosis Vasculitis Diffuse Lung Dis. 2011;28:58\u201361.","journal-title":"Sarcoidosis Vasculitis Diffuse Lung Dis"},{"issue":"2","key":"592_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/BF00862096","volume":"10","author":"M Schwab","year":"1996","unstructured":"Schwab M, Boswald M, Ludwig K, Wittekind C, Waldherr R, Ruder H. A patient with Down's syndrome and anti-neutrophilic cytoplasmic antibody-positive vasculitis. Pediatr Nephrol. 1996;10(2):249\u201350.","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"592_CR14","first-page":"1749","volume":"30","author":"A Niimi","year":"1992","unstructured":"Niimi A, Amitani R, Kurasawa T, et al. Two cases of idiopathic pulmonary hemosiderosis: analysis of chest CT findings. Nihon Kyobu Shikkan Gakkai Zasshi. 1992;30(9):1749\u201355.","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"592_CR15","volume-title":"A case report of idiopathic pulmonary haemosiderosis in a child with Down syndrome (Japenese only)","author":"YNI Sato","year":"1986","unstructured":"Sato YNI, Saeki Y. A case report of idiopathic pulmonary haemosiderosis in a child with Down syndrome (Japenese only); 1986."},{"issue":"7","key":"592_CR16","first-page":"580","volume":"49","author":"T Koyama","year":"1995","unstructured":"Koyama T, Tenou H, Kanadani T, Murakami M. A case of Down syndrome complicated with idiopathic pulmonary hemosiderosis. IRYO. 1995;49(7):580\u20133.","journal-title":"IRYO."},{"issue":"2","key":"592_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jpeds.2010.07.023","volume":"158","author":"KM McDowell","year":"2011","unstructured":"McDowell KM, Craven DI. Pulmonary complications of Down syndrome during childhood. J Pediatr. 2011;158(2):319\u201325.","journal-title":"J Pediatr"},{"issue":"1070","key":"592_CR18","doi-asserted-by":"publisher","first-page":"20160745","DOI":"10.1259\/bjr.20160745","volume":"90","author":"SM Mak","year":"2017","unstructured":"Mak SM, Strickland N, Gopalan D. Complications of pulmonary hypertension: a pictorial review. Br J Radiol. 2017;90(1070):20160745.","journal-title":"Br J Radiol"},{"key":"592_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jpeds.2018.06.031","volume":"202","author":"D Bush","year":"2018","unstructured":"Bush D, Galambos C, Ivy DD, Abman SH, Wolter-Warmerdam K, Hickey F. Clinical characteristics and risk factors for developing pulmonary hypertension in children with Down syndrome. J Pediatr. 2018;202:212\u20139 e212.","journal-title":"J Pediatr"},{"issue":"2","key":"592_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/pai.13133","volume":"31","author":"RHJ Verstegen","year":"2020","unstructured":"Verstegen RHJ, Chang KJJ, Kusters MAA. Clinical implications of immune-mediated diseases in children with down syndrome. Pediatr Allergy Immunol. 2020;31(2):117\u201323.","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"592_CR21","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1111\/ped.12612","volume":"57","author":"I Hori","year":"2015","unstructured":"Hori I, Nakaseko H, Kamei M, et al. Diffuse alveolar hemorrhage secondary to ANCA-associated vasculitis in a patient with Down syndrome. Pediatr Int. 2015;57(2):e45\u20137.","journal-title":"Pediatr Int"},{"issue":"4","key":"592_CR22","first-page":"446","volume":"51","author":"S Galant","year":"1983","unstructured":"Galant S, Nussbaum E, Wittner R, DeWeck AL, Heiner DC. Increased IgD milk antibody responses in a patient with Down's syndrome, pulmonary hemosiderosis and cor pulmonale. Ann Allergy. 1983;51(4):446\u20139.","journal-title":"Ann Allergy"},{"issue":"5","key":"592_CR23","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1136\/ard.2009.112458","volume":"69","author":"BA Fisher","year":"2010","unstructured":"Fisher BA, Charles P, Lundberg K, Gillespie KM, Newton RW, Venables PJ. Organ-specific autoantibodies but not anti-cyclic citrullinated peptides are a feature of autoimmunity in Down's syndrome. Ann Rheum Dis. 2010;69(5):939\u201340.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"592_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1440-1754.2007.01229.x","volume":"44","author":"SR da Rosa Utiyama","year":"2008","unstructured":"da Rosa Utiyama SR, Nisihara RM, Nass FR, Oliveira NP, Fiedler PT, de Messias-Reason IT. Autoantibodies in patients with Down syndrome: early senescence of the immune system or precocious markers for immunological diseases? J Paediatr Child Health. 2008;44(4):182\u20136.","journal-title":"J Paediatr Child Health"},{"issue":"8","key":"592_CR25","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.4049\/jimmunol.1400223","volume":"193","author":"M Gimenez-Barcons","year":"2014","unstructured":"Gimenez-Barcons M, Casteras A, Armengol Mdel P, et al. Autoimmune predisposition in Down syndrome may result from a partial central tolerance failure due to insufficient intrathymic expression of AIRE and peripheral antigens. J Immunol. 2014;193(8):3872\u20139.","journal-title":"J Immunol"},{"issue":"1","key":"592_CR26","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1038\/s41467-019-12739-9","volume":"10","author":"RK Powers","year":"2019","unstructured":"Powers RK, Culp-Hill R, Ludwig MP, et al. Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors. Nat Commun. 2019;10(1):4766.","journal-title":"Nat Commun"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00592-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-021-00592-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00592-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T15:03:06Z","timestamp":1626534186000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-021-00592-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,17]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["592"],"URL":"https:\/\/doi.org\/10.1186\/s12969-021-00592-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-297512\/v1","asserted-by":"object"}]},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,17]]},"assertion":[{"value":"3 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the Colorado Multiple Institutional Review Board under Protocol 10\u20130472.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No identifying data or images used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}